Personalized Medicine – News and Features

Some types of cancer are still extremely challenging to successfully treat. Once the disease has spread, it is very hard to cure. This article will explore the various types of tumor heterogeneity, how heterogeneity can impact treatment resistance and its influence on precision medicine.

A new analysis method can detect pathogens in blood samples faster and more accurately than blood cultures, which are the current state of the art for infection diagnosis.

Researchers have developed a cutting-edge blood test for the early detection of Alzheimer’s disease (AD) and mild cognitive impairment (MCI), surpassing remarkable accuracy rates of over 96% and 87% respectively.

Kathrin Herbst reviews the pros and cons of various single-cell technologies and discusses the need to move to functional readouts in the future.

Researchers have found important clues to how people make choices involving obtaining information about the future. The scientists identified a set of mental rules that governs decision-making about rewards.

The capabilities of trapped ion mobility spectrometry combined with automated data annotation software are driving new developments in lipid analysis. This article discusses how such advances are bringing the technology to more mainstream use, setting the foundations for future clinical research.

A study has shown that Rucaparib and its main metabolite M324 exhibit differential activities. The paper has analyzed Rucaparib and M324, making a computational prediction of the metabolite’s activity.

A new study by researchers at University of Limerick has demonstrated the impact resistance exercise training can have in the treatment of anxiety and depressive symptoms.

Researchers have developed a breakthrough blood test that could predict schizophrenia and psychosis risk, as well as match patients to the right treatment.

Researchers discovered that a large proportion of lupus patients have antibodies to a protein called “Sm”, which is tightly linked to worse disease outcomes.